Novo Nordisk announces changes in Executive Management
Bagsværd, Denmark, 7March 2023 – Novo Nordisk today announced the following changes in Executive Management.
Monique Carter, executive vice president (EVP), Global People & Organisation, has decided to leave Novo Nordisk to pursue an external opportunity, allowing her to be closer to her family in the UK. Monique Carter joined Novo Nordisk in 2018 as senior vice president (SVP) for People & Organisation, and in 2019 she was promoted to EVP, Global People & Organisation.
Tania Sabroe is promoted to EVP, Global People & Organisation, and will join Executive Management with immediate effect, succeeding Monique Carter. Tania Sabroe joined Novo Nordisk in August 2007 and comes from a position as SVP in Global People & Organisation. Previous to that she has held various positions of increasing importance and complexity in the field of people and organisation, sustainability and communication. Tania is a Danish national currently based in Switzerland where she worked in International Operations from 2013 to 2021.
Dave Moore is promoted to EVP, Corporate Development and will join Executive Management. Dave Moore joined Novo Nordisk in September 2022 as SVP for Corporate Development with the responsibility for strategy and business development. Before joining Novo Nordisk, Dave Moore held various leadership roles in the pharmaceutical industry in the US, working in international large pharma companies, biotech companies and private equity. From 2017 to 2019, Dave Moore was SVP for commercial operations in Novo Nordisk in the US. Dave is a US national and is based in the US.
With these changes, Executive Management will have the following members as of 7 March 2023:
- Lars Fruergaard Jørgensen, president and CEO
- Maziar Mike Doustdar, EVP, International Operations*
- Ludovic Helfgott, EVP, Rare disease*
- Karsten Munk Knudsen, EVP, chief financial officer
- Doug Langa, EVP, North America Operations*
- Martin Holst Lange, EVP, Development
- Dave Moore, EVP, Corporate Development*
- Tania Sabroe, EVP, People & Organisation*
- Marcus Schindler, EVP, chief scientific officer, Research & Early Development
- Camilla Sylvest, EVP, Commercial Strategy and Corporate Affairs
- Henrik Wulff, EVP, Product Supply, Quality & IT
* Not registered as an executive with the Danish Business Authority.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 54,400 people in 80 countries and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed on the New York Stock Exchange (NVO). For more information, visit novonordisk.com,Facebook, Twitter, LinkedIn andYouTube.
Contact for further information
| Media: | |
| Ambre Brown Morley +45 3079 9289 abmo@novonordisk.com | Natalia Salomao Abrahao (US) +1 848 304 1027 niaa@novonordisk.com |
| Investors: | |
| Daniel Muusmann Bohsen +45 3075 2175 dabo@novonordisk.com | Jacob Martin Wiborg Rode +45 3075 5956 jrde@novonordisk.com |
| David Heiberg Landsted +45 3077 6915 dhel@novonordisk.com | Mark Joseph Root (US) +1 848 213 3219 mjhr@novonordisk.com |
Company announcement No 17 / 2023
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Kitron: Minutes from Annual General Meeting 202425.4.2024 11:45:00 CEST | Press release
(2024-04-25) Kitron ASA held its Annual General Meeting on 25 April 2024. 113,103,255 shares, amounting to 57.06 per cent of the share capital, were represented at the meeting. All proposals were resolved as presented in the notice issued on 4 April 2024. After the general meeting, the board of Kitron comprises the following shareholder- and employee-elected members: Shareholder-elected members: Tuomo Lähdesmäki (Chairperson, re-elected) Maalfrid Brath (re-elected) Michael Lundgaard Thomsen (re-elected) Petra Grandinson (re-elected) Gyrid Skalleberg Ingerø (elected) Employee elected members: Tone Aas Henriette Stene Jarle Larsen The Annual General Meeting approved the proposed dividend of NOK 0.75 per share for shareholders registered in Kitron's shareholder register with the Norwegian Central Securities Depository (Euronext Securities Oslo, formerly named Euronext VPS) as of the expiry of 29 April 2024 based on normal T+2 settlement. Kitron's shares will be traded on the Oslo Stock Ex
Invitation to UPM's Capital Markets Day 202425.4.2024 11:45:00 CEST | Press release
(UPM, Helsinki, 25 April 2024 at 12:45 EEST) – UPM invites investors, analysts and bankers to a Capital Markets Day 2024 taking place in London on Thursday, 5 September 2024. Participants of the event will meet the President and CEO Massimo Reynaudo and other members of the UPM Group executive team and hear their views. This is an excellent opportunity to have dialogues on UPM's strategy, businesses, performance, sustainability and growth opportunities. In addition to the onsite event, there will a live webcast of the presentations, starting at 13:00 local time. You can ask questions online. Recordings of the presentations will be published on the UPM web site after the event. Registration for onsite and webcast event is open. Preliminary timetable of the Capital Markets Day (local time): 12.00–13:00 Registration and mingling lunch 13:00–15:00 Presentations and webcast 15:00–16:00 Coffee and discussion The venue of the event: LSEG (London Stock Exchange Group) 10 Paternoster Square Lon
Kitron: Avholdt ordinær generalforsamling 202425.4.2024 11:45:00 CEST | Pressemelding
(2024-04-25) Kitron ASA avholdt ordinær generalforsamling 25. april 2024. 113 103 255 aksjer, som utgjør 57,06 prosent av aksjekapitalen, var representert på generalforsamlingen. Alle forslag ble vedtatt slik de er gjengitt i innkallingen utsendt 4. april 2024. Kitrons styre har nå følgende aksjonær- og ansattvalgt sammensetting: Valgt av aksjonærene: Tuomo Lähdesmäki (Leder, gjenvalgt) Maalfrid Brath (gjenvalgt) Michael Lundgaard Thomsen (gjenvalgt) Petra Grandinson (gjenvalgt) Gyrid Skalleberg Ingerø (valgt) Valgt av de ansatte: Tone Aas Henriette Stene Jarle Larsen Generalforsamlingen godkjente det foreslåtte utbytte på NOK 0,75 per aksje for aksjonærer registrert i Kitrons aksjeeierregister i Verdipapirsentralen ASA (Euronext Securities Oslo, tidligere kalt Euronext VPS) per utløpet av 29. april 2024, basert på normalt T + 2 oppgjør. Kitrons aksjer vil handles på Oslo Børs eksklusive retten til å motta utbytte 26. april 2024. Utbytte ventes utbetalt på eller omkring 16. mai 2024. P
Avenir LNG Limited orders 2 x 20,000cbm LNG Bunker and Supply Vessels25.4.2024 11:41:19 CEST | Press release
London, 25th April 2024, Avenir LNG Limited (NOTC: AVENIR or the “Company”) announces today that it has entered into a shipbuilding contract with Nantong CIMC Sinopacific Offshore & Engineering Co. Ltd (“SOE”) in China, a subsidiary of CIMC Enric, for two 20,000cbm LNG Bunker & Supply Vessels which are scheduled to be delivered in Q4 2026 and Q1 2027. The newbuildings will feature new Type C tank designs, lower boil off rates, the latest engine technologies, hull form optimisation, and subcoolers which offer carbon emission reductions and minimises cargo losses compared to other vessels of this size. The vessel design enables maximum compatibility and versatility for loading and discharging LNG and BioLNG to a wide range of receiving vessels and terminals reflecting the growing needs of our customers. This major new investment programme marks the second phase of growth for the Company, increasing the fleet by 40% and 80% in terms of total capacity. This order will further enhance Aveni
HSBC Continental Europe: Pre Stabilisation Notice25.4.2024 11:40:25 CEST | Press release
Werfen, S.A. Pre Stabilisation Notice PARIS, April 25, 2024 (GLOBE NEWSWIRE) -- HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities The securities:Issuer:Werfen, S.A.Guarantor (if any):naAggregate nominal amount:EUR 500,000,000Description:Fixed rate due 3rd May 2030Offer price:TBC Other offer terms:Stabilisation:Stabilising Manager(s):HSBC Continental Europe, BBVA, BNP Paribas, CaixaBank, Citigroup, Deutsche Bank, JP MorganStabilisation period expected to start on:25th April 2024Stabilisation period expected to end no later than:31st May 2024Existence, maximum size & conditions of use of over-allotment facility[1]:5% of the aggregate nominal amountStabilisation Venue(s)Over the counter (OTC) In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view